TickerLeague

Buyback Spend for Boston Scientific (BSX)

Buyback Spend for Boston Scientific (BSX): headline value $0. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$0

YoY change

N/A

5Y CAGR

-100.0%

Peak year (2005)

$734.00M

Latest annual

$0

Buyback Spend history chart for Boston Scientific (BSX) from 1991 to 2025

Buyback Spend history table for Boston Scientific (BSX) from 1991 to 2025

Fiscal yearPeriod endedReportedBuyback SpendYoY
2025$0
2024$0
2023$0-100.0%
2022$136.00M
2021$0-100.0%
2020$535.00M
2019$0
2018$0
2017$0
2016$0
2015$0-100.0%
2014$125.00M-75.0%
2013$500.00M-16.7%
2012$600.00M+22.0%
2011$492.00M
2010$0
2009$0
2008$0-100.0%
2007$60.00M
2006$0-100.0%
2005$734.00M+103.9%
2004$360.00M-36.8%
2003$570.00M
2002$0
2001$0-100.0%
2000$222.00M+74.8%
1999$127.00M
1998$0-100.0%
1997$187.00M+193.1%
1996$63.80M
1995$0
1994$0-100.0%
1993$57.40M
1992$0
1991$0

Buyback Spend values are taken from Boston Scientific's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

Boston Scientific (BSX) most recent annual buyback spend stands at $0 (2025).

Across 2020–2025 (5 years), Boston Scientific buyback spend produced a CAGR of -100.0% – with a net decline across the window.

Between 2005 and 2025, Boston Scientific buyback spend plunged 100.0%, falling from $734.00M to $0.

The dataset's maximum buyback spend sits at $734.00M (2005); the minimum reading of $0 dates to 1991.

Among 8 Healthcare peers, Boston Scientific (BSX) ranks 8th; the peer median for buyback spend is $2.75B.

Boston Scientific Buyback Spend by Year

Boston Scientific Buyback Spend 2025: $0

Boston Scientific buyback spend in 2025 was $0.

Boston Scientific Buyback Spend 2024: $0

Boston Scientific buyback spend in 2024 was $0.

Boston Scientific Buyback Spend 2023: $0

Boston Scientific buyback spend in 2023 was $0, plunged 100.0% below 2022.

Boston Scientific Buyback Spend 2022: $136.00M

Boston Scientific buyback spend in 2022 was $136.00M.

Boston Scientific Buyback Spend 2021: $0

Boston Scientific buyback spend in 2021 was $0.

See more financial history for Boston Scientific (BSX).

Sector peers — Buyback Spend

Companies in the same sector as Boston Scientific, ranked by their latest buyback spend.

CompanyBuyback SpendSector
Johnson & Johnson (JNJ)$5.95BHealthcare
UnitedHealth Group Incorporated (UNH)$5.54BHealthcare
Merck & Co., Inc. (MRK)$5.08BHealthcare
Eli Lilly and Company (LLY)$4.11BHealthcare
Novo Nordisk A/S (NVO)$1.39BHealthcare
AbbVie Inc. (ABBV)$980.00MHealthcare
AstraZeneca PLC (AZN)$719.66MHealthcare
Amgen Inc. (AMGN)$0Healthcare

Frequently asked questions

What is Boston Scientific's buyback spend?

Latest reported buyback spend for Boston Scientific (BSX) is $0 (period ending December 31, 2025).

What is the long-term growth rate of Boston Scientific buyback spend?

Boston Scientific (BSX) buyback spend compound annual growth rate is -100.0% over the most recent 5 years available.

When did Boston Scientific buyback spend hit its highest annual value?

Boston Scientific buyback spend reached its highest annual value of $734.00M in 2005.

What was Boston Scientific buyback spend in 2024?

Boston Scientific (BSX) buyback spend in 2024 was $0.

What was Boston Scientific buyback spend in 2025?

Boston Scientific (BSX) buyback spend in 2025 was $0.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.